Column

Column|Stem Cell & Regenerative Medicine Insights

2026.07.09

Can Eyebrow and Eyelash Thinning Be Treated the Same Way as Scalp Hair Loss? — Extremely Short Hair Cycles and Stem Cell Conditioned Media as an Option

2026.07.09

Oral Minoxidil vs. Topical Minoxidil — How to Choose, Read Through Systemic Exposure, Delivery to the Follicle, and the Role of Stem Cell Conditioned Media

2026.07.09

Don’t Overlook Lichen Planopilaris — How to Distinguish ‘Inflammation-Driven Follicle Loss’ from AGA, and the Boundaries of Stem Cell Conditioned Media

2026.07.08

Can the “JAK Inhibitor Grows Hair” Story Be Applied to All Hair Loss? Drawing the Line Between Alopecia Areata and AGA from the Perspective of Stem Cell Conditioned Media

2026.07.08

Scalp Injection for Patients Taking Blood Thinners: Anticoagulants, Antiplatelets, and Bruising Risk

2026.07.08

Dutasteride vs Finasteride: How the Range of 5α-Reductase Inhibition Differs — and Where Stem Cell Conditioned Media Fits as a Complement to the Follicular Microenvironment

2026.07.08

When postpartum hair loss won’t stop even after a year, it may be “postpartum thyroiditis” — the thyroid pitfall to check before writing it off as ordinary shedding, and where stem cell conditioned media fits in

2026.07.07

Do Growth Factors Break Down When Frozen and Thawed? The Storage Stability and Cold Chain Science Behind Stem Cell Conditioned Media

2026.07.07

Can Postpartum Hair Loss Treatment Continue While Breastfeeding? A Framework for What to Do Now and What to Wait For, Based on Milk Transfer and Drug Safety

1 … 16 17 18 19 20 … 32